Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2021

Open Access 01-12-2021 | Bronchial Asthma | Research article

Association between body mass index and patient-reported-outcome questionnaire scores (CAT™, ACT™, mMRC dyspnoea scale, IPAQ) in Ukraine, Kazakhstan and Azerbaijan: results of the CORE study

Authors: D. Nugmanova, Y. Feshchenko, L. Iashyna, M. Polianska, K. Malynovska, I. Stafeyeva, J. Makarova, A. Vasylyev

Published in: BMC Pulmonary Medicine | Issue 1/2021

Login to get access

Abstract

Background

The overweight/obese population (evaluated by a body mass index, BMI) represents a global health problem and contributes to the development of various chronic diseases. In this epidemiological study we evaluated this relationship by analyzing patient-reported questionnaires related to respiratory function, physical activity and BMI.

Methods

In 2013–2015, adult residents of selected cities were enrolled to this study in: Ukraine (M/F: 403/561), Kazakhstan (M/F = 348/597) and Azerbaijan (M/F: 389/544). Height was measured using a vertical measuring board, and body weight was measured by using portable digital scales. All participants were interviewed using CAT™, mMRC scale and IPAQ; respondents who also reported wheezing or whistling chest sounds during the previous 12 months additionally ACT™.

Results

45.4% of respondents in Ukraine, 47.6% in Kazakhstan and 54.9% of respondents in Azerbaijan were found to be overweight/obese (BMI ≥ 25 kg/m2). The mean CAT™ total score among this population versus those respondents with a normal weight was 5.2 versus 3.6 (Ukraine, p < 0.001), 4.2 versus 2.9 (Kazakhstan, p < 0.001) and 5.9 versus 4.3 (Azerbaijan, p < 0.001). The number of respondents without airflow limitations (mMRC score 0) among overweight/obese respondents versus normal weight respondents was 298 (68.2%) versus 456 (86.7%) in Ukraine, 261 (58.1%) versus 387 (78.2%) in Kazakhstan and 343 (67.1%) versus 345 (82.3%) in Azerbaijan. The ACT™ total score between overweight/obese respondents and normal weight respondents was not statistically different. IPAQ showed a tendency towards a higher proportion of “low activity” results (compared to “moderate” and “high”) in the overweight/obese subgroup (24.7% vs. 23.8% in Kazakhstan, 18.5% vs. 14.6% in Azerbaijan), and in Ukraine this difference was significant (12.4% vs. 5.2%, p < 0.001).

Conclusion

CAT™ and mMRC are widely used tools for respiratory function assessment. Despite CAT™ scores being close to a normal value (< 5), the relationship of both CAT™ and mMRC scores with being overweight/obese was demonstrated in the general adult population of three CIS countries. IPAQ may also be a useful instrument for measuring activity level however, more objective studies are required to evaluate the relationship between BMI and physical activity.
Appendix
Available only for authorised users
Literature
2.
go back to reference Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224–60.CrossRef Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224–60.CrossRef
9.
go back to reference Beuther DA, Sutherland ER. Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med. 2007;175(7):661–6.CrossRef Beuther DA, Sutherland ER. Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med. 2007;175(7):661–6.CrossRef
10.
go back to reference Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005–12.CrossRef Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005–12.CrossRef
12.
go back to reference Lainscak M, von Haehling S, Doehner W, et al. Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease. J Cachexia Sarcopenia Muscle. 2011;2(2):81–6.CrossRef Lainscak M, von Haehling S, Doehner W, et al. Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease. J Cachexia Sarcopenia Muscle. 2011;2(2):81–6.CrossRef
13.
go back to reference Jones P, Harding G, Berry P, et al. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648–54.CrossRef Jones P, Harding G, Berry P, et al. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648–54.CrossRef
14.
go back to reference Ekici A, Bulcun E, Karakoc T, Senturk E, Ekici M. Factors associated with quality of life in subjects with stable COPD. Respir Care. 2015;60:1585-91.CrossRef Ekici A, Bulcun E, Karakoc T, Senturk E, Ekici M. Factors associated with quality of life in subjects with stable COPD. Respir Care. 2015;60:1585-91.CrossRef
15.
go back to reference Schatz M, Sorkness C, Li J, Marcus P, Murray J, Nathan R, et al. Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol. 2006;117(3):549–56.CrossRef Schatz M, Sorkness C, Li J, Marcus P, Murray J, Nathan R, et al. Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol. 2006;117(3):549–56.CrossRef
16.
go back to reference Craig C, Marshall A, Sjöström M, Bauman A, Booth M, Ainsworth B, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381–95.CrossRef Craig C, Marshall A, Sjöström M, Bauman A, Booth M, Ainsworth B, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381–95.CrossRef
19.
go back to reference Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CPM, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J - Standardisation of spirometry. Series “ATS/ERS task force: standardisation of lung function testing”. Edited by V. Brusasco, R. Crapo and G. Viegi. Number 2 in this Series. Eur Respir J 2005; 26: 319–338. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CPM, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J - Standardisation of spirometry. Series “ATS/ERS task force: standardisation of lung function testing”. Edited by V. Brusasco, R. Crapo and G. Viegi. Number 2 in this Series. Eur Respir J 2005; 26: 319–338.
21.
go back to reference Levy ML, Fletcher M, Price DB, Hausen T, Halbert RJ, Yawn BP. International Primary Care Respiratory Group (IPCRG) Guidelines: Diagnosis of respiratory diseases in primary care. Prim Care Respir J. 2006;15(1):20–34.CrossRef Levy ML, Fletcher M, Price DB, Hausen T, Halbert RJ, Yawn BP. International Primary Care Respiratory Group (IPCRG) Guidelines: Diagnosis of respiratory diseases in primary care. Prim Care Respir J. 2006;15(1):20–34.CrossRef
22.
go back to reference Allergic Rhinitis and its Impact on Asthma (ARIA). Management of Allergic Rhinitis and Impact on Asthma - Pocket Guide, 2007. Based on the 2007 ARIA workshop report and the IPAG handbook. Avaiable from: http://www.whiar.org Allergic Rhinitis and its Impact on Asthma (ARIA). Management of Allergic Rhinitis and Impact on Asthma - Pocket Guide, 2007. Based on the 2007 ARIA workshop report and the IPAG handbook. Avaiable from: http://​www.​whiar.​org
23.
go back to reference Clopper C, Pearson ES. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika. 1934;26:404–13.CrossRef Clopper C, Pearson ES. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika. 1934;26:404–13.CrossRef
24.
go back to reference Nugmanova D, Sokolova L, Feshchenko Y, Iashyna L, Gyrina O, Malynovska K, Mustafayev I, Aliyeva G, Makarova J, Vasylyev A, Tariq L. The prevalence, burden and risk factors associated with bronchial asthma in commonwealth of independent states countries (Ukraine, Kazakhstan and Azerbaijan): results of the CORE study. BMC Pulm Med. 2018;18(1):110. https://doi.org/10.1186/s12890-018-0676-7 (PubMed PMID: 29976177).CrossRefPubMedPubMedCentral Nugmanova D, Sokolova L, Feshchenko Y, Iashyna L, Gyrina O, Malynovska K, Mustafayev I, Aliyeva G, Makarova J, Vasylyev A, Tariq L. The prevalence, burden and risk factors associated with bronchial asthma in commonwealth of independent states countries (Ukraine, Kazakhstan and Azerbaijan): results of the CORE study. BMC Pulm Med. 2018;18(1):110. https://​doi.​org/​10.​1186/​s12890-018-0676-7 (PubMed PMID: 29976177).CrossRefPubMedPubMedCentral
25.
go back to reference Nugmanova D, Feshchenko Y, Iashyna L, Gyrina O, Malynovska K, Mammadbayov E, Akhundova I, Nurkina N, Tariq L, Makarova J, Vasylyev A. The prevalence, burden and risk factors associated with chronic obstructive pulmonary disease in Commonwealth of Independent States (Ukraine, Kazakhstan and Azerbaijan): results of the CORE study. BMC Pulm Med. 2018;18(1):26. https://doi.org/10.1186/s12890-018-0589-5.CrossRefPubMedPubMedCentral Nugmanova D, Feshchenko Y, Iashyna L, Gyrina O, Malynovska K, Mammadbayov E, Akhundova I, Nurkina N, Tariq L, Makarova J, Vasylyev A. The prevalence, burden and risk factors associated with chronic obstructive pulmonary disease in Commonwealth of Independent States (Ukraine, Kazakhstan and Azerbaijan): results of the CORE study. BMC Pulm Med. 2018;18(1):26. https://​doi.​org/​10.​1186/​s12890-018-0589-5.CrossRefPubMedPubMedCentral
26.
go back to reference Jones PW, Shahrour N, Nejjari C, Lahlou A, Doble A, Rashid N, El Hasnaoui A; BREATHE Study Group. Psychometric evaluation of the COPD assessment test: data from the BREATHE study in the Middle East and North Africa region. Respir Med. 2012;106 Suppl 2:S86–99. doi: https://doi.org/10.1016/S0954-6111(12)70017-3. Jones PW, Shahrour N, Nejjari C, Lahlou A, Doble A, Rashid N, El Hasnaoui A; BREATHE Study Group. Psychometric evaluation of the COPD assessment test: data from the BREATHE study in the Middle East and North Africa region. Respir Med. 2012;106 Suppl 2:S86–99. doi: https://​doi.​org/​10.​1016/​S0954-6111(12)70017-3.
29.
go back to reference Ghobadi H, Fouladi N, Beukaghazadeh K, Ansarin K. Association of high sensitive CRP level and COPD assessment test scores with clinically important predictive outcomes in stable COPD patients. Tanaffos. 2015;14(1):34–41.PubMedPubMedCentral Ghobadi H, Fouladi N, Beukaghazadeh K, Ansarin K. Association of high sensitive CRP level and COPD assessment test scores with clinically important predictive outcomes in stable COPD patients. Tanaffos. 2015;14(1):34–41.PubMedPubMedCentral
30.
go back to reference Gianjoppe-Santos J, Nyssen SM, Pessoa BV, et al. Chronic obstructive pulmonary disease Assessment Test in assessing of patients with chronic obstructive pulmonary disease: there is a relationship with activities of daily living and mortality predictor index? A cross-sectional study. Fisioter Pesqui. 2013;20(4):379–86. https://doi.org/10.1590/S1809-29502013000400013.CrossRef Gianjoppe-Santos J, Nyssen SM, Pessoa BV, et al. Chronic obstructive pulmonary disease Assessment Test in assessing of patients with chronic obstructive pulmonary disease: there is a relationship with activities of daily living and mortality predictor index? A cross-sectional study. Fisioter Pesqui. 2013;20(4):379–86. https://​doi.​org/​10.​1590/​S1809-2950201300040001​3.CrossRef
34.
go back to reference Phadke SSD, Mahajani AG, Ramakrishnan KS. Analysis of modified medical research council scale and baseline dyspnea index to evaluate obesity related breathlessness. Int J Emerging Trends Sci Technol 2014; 1(5):615–619. Phadke SSD, Mahajani AG, Ramakrishnan KS. Analysis of modified medical research council scale and baseline dyspnea index to evaluate obesity related breathlessness. Int J Emerging Trends Sci Technol 2014; 1(5):615–619.
39.
go back to reference Tehard B, Saris WH, Astrup A, et al. Comparison of two physical activity questionnaires in obese subjects: the NUGENOB study. Med Sci Sports Exerc. 2005;37(9):1535–41.CrossRef Tehard B, Saris WH, Astrup A, et al. Comparison of two physical activity questionnaires in obese subjects: the NUGENOB study. Med Sci Sports Exerc. 2005;37(9):1535–41.CrossRef
Metadata
Title
Association between body mass index and patient-reported-outcome questionnaire scores (CAT™, ACT™, mMRC dyspnoea scale, IPAQ) in Ukraine, Kazakhstan and Azerbaijan: results of the CORE study
Authors
D. Nugmanova
Y. Feshchenko
L. Iashyna
M. Polianska
K. Malynovska
I. Stafeyeva
J. Makarova
A. Vasylyev
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2021
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-021-01542-2

Other articles of this Issue 1/2021

BMC Pulmonary Medicine 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.